CO2017005357A2 - Un proceso para la fabricación de idalopirdina - Google Patents
Un proceso para la fabricación de idalopirdinaInfo
- Publication number
- CO2017005357A2 CO2017005357A2 CONC2017/0005357A CO2017005357A CO2017005357A2 CO 2017005357 A2 CO2017005357 A2 CO 2017005357A2 CO 2017005357 A CO2017005357 A CO 2017005357A CO 2017005357 A2 CO2017005357 A2 CO 2017005357A2
- Authority
- CO
- Colombia
- Prior art keywords
- idalopirdine
- manufacture
- describes
- preparation
- pharmaceutically acceptable
- Prior art date
Links
- YBAWYTYNMZWMMJ-UHFFFAOYSA-N 2-(6-fluoro-1h-indol-3-yl)-n-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]ethanamine Chemical compound FC(F)C(F)(F)COC1=CC=CC(CNCCC=2C3=CC=C(F)C=C3NC=2)=C1 YBAWYTYNMZWMMJ-UHFFFAOYSA-N 0.000 title abstract 3
- 229950005109 idalopirdine Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201400721 | 2014-12-12 | ||
| PCT/EP2015/079209 WO2016091997A1 (fr) | 2014-12-12 | 2015-12-10 | Procédé de fabrication d'idalopirdine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2017005357A2 true CO2017005357A2 (es) | 2017-09-20 |
Family
ID=59011415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2017/0005357A CO2017005357A2 (es) | 2014-12-12 | 2017-05-26 | Un proceso para la fabricación de idalopirdina |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP3230265A1 (fr) |
| JP (1) | JP2017537128A (fr) |
| KR (1) | KR20170093821A (fr) |
| CN (1) | CN107001266A (fr) |
| AU (1) | AU2015359347A1 (fr) |
| BR (1) | BR112017012021A2 (fr) |
| CA (1) | CA2968770A1 (fr) |
| CL (1) | CL2017001466A1 (fr) |
| CO (1) | CO2017005357A2 (fr) |
| IL (1) | IL252471A0 (fr) |
| MA (1) | MA41148A (fr) |
| MX (1) | MX2017007510A (fr) |
| RU (1) | RU2017120216A (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015362394C1 (en) | 2014-12-12 | 2021-01-28 | Japan Tobacco Inc. | Dihydropyrimidine-2-one compounds and medicinal uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3042685A (en) * | 1962-07-03 | Process of making g-fluoro tryptamine | ||
| AR065804A1 (es) * | 2007-03-23 | 2009-07-01 | Smithkline Beecham Corp | Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento |
| TW201139370A (en) * | 2009-12-23 | 2011-11-16 | Lundbeck & Co As H | Processes for the manufacture of a pharmaceutically active agent |
-
2015
- 2015-12-09 MA MA041148A patent/MA41148A/fr unknown
- 2015-12-10 AU AU2015359347A patent/AU2015359347A1/en not_active Abandoned
- 2015-12-10 KR KR1020177015206A patent/KR20170093821A/ko not_active Withdrawn
- 2015-12-10 JP JP2017531139A patent/JP2017537128A/ja active Pending
- 2015-12-10 MX MX2017007510A patent/MX2017007510A/es unknown
- 2015-12-10 CA CA2968770A patent/CA2968770A1/fr not_active Abandoned
- 2015-12-10 BR BR112017012021A patent/BR112017012021A2/pt not_active Application Discontinuation
- 2015-12-10 RU RU2017120216A patent/RU2017120216A/ru not_active Application Discontinuation
- 2015-12-10 CN CN201580065028.6A patent/CN107001266A/zh active Pending
- 2015-12-10 EP EP15821029.4A patent/EP3230265A1/fr not_active Withdrawn
-
2017
- 2017-05-23 IL IL252471A patent/IL252471A0/en unknown
- 2017-05-26 CO CONC2017/0005357A patent/CO2017005357A2/es unknown
- 2017-06-08 CL CL2017001466A patent/CL2017001466A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3230265A1 (fr) | 2017-10-18 |
| KR20170093821A (ko) | 2017-08-16 |
| CA2968770A1 (fr) | 2016-06-16 |
| CL2017001466A1 (es) | 2018-01-05 |
| CN107001266A (zh) | 2017-08-01 |
| MA41148A (fr) | 2017-10-17 |
| JP2017537128A (ja) | 2017-12-14 |
| AU2015359347A1 (en) | 2017-06-08 |
| IL252471A0 (en) | 2017-07-31 |
| MX2017007510A (es) | 2017-08-22 |
| RU2017120216A (ru) | 2019-01-15 |
| BR112017012021A2 (pt) | 2018-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283258A (en) | Treatment of hypoparathyroidism | |
| MX2022016566A (es) | Composiciones que comprenden una caseina y metodos para producir las mismas. | |
| CY1124521T1 (el) | Σκευασματα αντισωματος anti-cd19 | |
| IL263709A (en) | Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use | |
| CU20160185A7 (es) | Compuestos de heteroarilo para la inhibición de cinasa | |
| TWD187539S (zh) | 鞋之部分 | |
| TWD187540S (zh) | 鞋之部分 | |
| HUE062136T2 (hu) | Eljárás hõre lágyuló kopásálló fólia elõállítására | |
| LT3429571T (lt) | Sd1 inhibitorių deriniai, skirti neoplastinių ligų gydymui | |
| MX2016014247A (es) | Conjugados de anticuerpo-farmaco anti-proteina tirosina quinasa 7 (anti-ptk7). | |
| TWD173737S (zh) | 肌肉鍛鍊機器 | |
| TWD176442S (zh) | 相機模組之部分 | |
| TWD173398S (zh) | 瓶子之部分 | |
| EA201790627A1 (ru) | СТИМУЛЯТОРЫ рГЦ | |
| GT201700058A (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos | |
| CL2016002338A1 (es) | Uso de un compuesto que es ácido r-2-4-2-etoxi-3-4-trifluorometilfenoxipropil-tio-2-metilfenoxi acético, para el tratamiento de una enfermedad colestásica intrahepática . | |
| IL251859A0 (en) | Methotrexate formulation | |
| EP3556345A4 (fr) | Comprimé à désintégration orale comprenant un composé de carbamate | |
| AR101368A1 (es) | Forma cristalina de sofosbuvir y proceso para su preparación | |
| MX2018012900A (es) | Uso de beta-agonistas del receptor de la hormona tiroidea. | |
| EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
| ECSP16086196A (es) | Sales farmacéuticamente aceptables de enantiomeros de pirlindole para uso en medicina | |
| EA201700060A1 (ru) | Терапевтическое средство для кератоконъюнктивальных расстройств | |
| CL2017001466A1 (es) | Un proceso para la fabricación de idalopirdina | |
| HUP1600415A2 (en) | Pimavanserin salts for the manufacture of pharmaceutical formulations |